Audience -All Patients & Families-Adults & Aging-Chapters-Donors & Supporters-Healthcare Providers-Kids & Young Adults-Men-Payers-Spanish Speaking Individuals-Undiagnosed-Women & Girls Type of Bleeding Disorder -All Bleeding Disorders-Hemophilia-Inhibitors-Rare Bleeding Disorders-Von Willebrand Disease Topic -Advocacy-Awareness-Blood & Product Safety-Bone & Joint Health-Community-COVID-19-Digital Health-Diversity, Equity & Inclusion-Fitness & Nutrition-Future Therapies-Health Equity-Healthcare Insurance-HIV & Hepatitis C-Mental Health-Pain Management-Sexual & Reproductive Health-Research-Treatment & Care 25 Jan Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A Jan 25, 2023 - Jan 25, 2023 26 Oct Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A Oct 26, 2022 - Oct 26, 2022 05 Oct Parental perspectives on gene therapy for children with haemophilia: The Exigency Study Oct 5, 2022 - Oct 5, 2022 17 Aug An exploration of why men with severe haemophilia might not want gene therapy: The exigency study Aug 17, 2022 - Aug 17, 2022 04 May Multiyear Factor VIII Expression after Adeno‐associated Virus Gene Transfer for Hemophilia A May 4, 2022 - May 4, 2022 27 Apr AAV Antibodies Update Apr 27, 2022 - Apr 27, 2022 30 Mar Shared Decision-Making: An Essential Element to Patient-Centricity Mar 30, 2022 02 Feb Applications of Gene Editing in Medical Science Feb 2, 2022 - Feb 2, 2022 27 Oct Platelet Derived Factor VIII: A Different Approach to Gene Therapy Oct 27, 2021 - Oct 27, 2021 01 Sep Gene Therapy for Inheritable Bleeding Disorders Sep 1, 2021 - Sep 1, 2021 28 Jul Ensuring Health Equity with Emerging Therapies Jul 28, 2021 - Jul 28, 2021 16 Jun The Current Status of Gene Therapy in Hemophilia Jun 16, 2021 - Jun 16, 2021 21 Apr Wednesday Webinar: WFH Gene Therapy Registry to Track Long Term Safety and Efficacy Apr 21, 2021 - Apr 21, 2021 05 Oct Gene Therapy: What's New & What's Next Webinar Oct 5, 2020
25 Jan Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A Jan 25, 2023 - Jan 25, 2023
26 Oct Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A Oct 26, 2022 - Oct 26, 2022
05 Oct Parental perspectives on gene therapy for children with haemophilia: The Exigency Study Oct 5, 2022 - Oct 5, 2022
17 Aug An exploration of why men with severe haemophilia might not want gene therapy: The exigency study Aug 17, 2022 - Aug 17, 2022
04 May Multiyear Factor VIII Expression after Adeno‐associated Virus Gene Transfer for Hemophilia A May 4, 2022 - May 4, 2022
27 Oct Platelet Derived Factor VIII: A Different Approach to Gene Therapy Oct 27, 2021 - Oct 27, 2021
21 Apr Wednesday Webinar: WFH Gene Therapy Registry to Track Long Term Safety and Efficacy Apr 21, 2021 - Apr 21, 2021
